Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patients.

Tsuyoshi TakedaTakashi SasakiKoshiro FukudaTakafumi MieTakaaki FurukawaYuto YamadaAkiyoshi KasugaMasato MatsuyamaMasato OzakaNaoki Sasahira

Published in: International journal of clinical oncology (2020)

We demonstrated that GnP-induced ILD occurred in 2.2% of PC patients with no mortality and OS did not differ according to ILD occurrence. Furthermore, we clarified that ABO blood type B was an independent risk factor for developing ILD in PC patients receiving GnP.

Keyphrases

interstitial lung disease
systemic sclerosis
rheumatoid arthritis
idiopathic pulmonary fibrosis
high glucose
diabetic rats
risk assessment
drug induced
cardiovascular events
radiation therapy
risk factors
squamous cell carcinoma
advanced non small cell lung cancer
tyrosine kinase